衰弱对原发性脑肿瘤手术患者结局的预后效用:一项Meta分析
该系统综述与Meta分析纳入13项研究,评估衰弱对原发性脑肿瘤手术结局的预测价值。结果显示衰弱与住院时间(效应量0.94;95%CI 0.37, 1.51;P=0.00)、再入院(效应量0.82;95%CI 0.23, 1.41;P=0.01)、非计划出院(效应量1.07;95%CI 0.48, 1.65;P=0.00)、术后死亡率(效应量1.48;95%CI 0.81, 2.02;P=0.00)及总生存(效应量1.53;95%CI 0.29, 2.76;P=0.02)相关,但与术后并发症无统计学显著关联(效应量10.31;95%CI -5.88, 26.86;P=0.21)。
要点
- 衰弱与原发性脑肿瘤术后住院时间延长相关(效应量0.94;95%CI 0.37, 1.51;P=0.00)。
- 衰弱与再入院、非计划出院、术后死亡率及总生存相关,P值分别为0.01、0.00、0.00、0.02。
- 衰弱预测术后并发症无统计学显著性(效应量10.31;95%CI -5.88, 26.86;P=0.21)。
核心结论
- 本研究表明衰弱与术后死亡率、再入院、非计划出院、住院时间或总生存相关性很小,衰弱在这些方面意义较小,但在预测原发性脑肿瘤术后并发症方面无统计学显著性。
研究设计与样本
- 系统综述与Meta分析,系统检索PubMed、EMBASE和SCOPUS数据库,纳入13项研究,评估衰弱对原发性脑肿瘤手术结局的预测能力。
主要发现
- 住院时间效应量0.94(95%CI 0.37, 1.51;P=0.00)。
- 术后并发症效应量10.31(95%CI -5.88, 26.86;P=0.21)。
- 再入院效应量0.82(95%CI 0.23, 1.41;P=0.01)。
- 非计划出院效应量1.07(95%CI 0.48, 1.65;P=0.00)。
- 术后死亡率效应量1.48(95%CI 0.81, 2.02;P=0.00),总生存效应量1.53(95%CI 0.29, 2.76;P=0.02)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frailty refers to a state of weakness that can arise due to age or illnesses, and frailty predisposes individuals to several adverse health outcomes. This has been postulated to prognosticate the outcome of various surgeries, including surgeries for primary brain tumors; however, no meta-analysis has validated this finding. METHODS: We conducted a systematic review and meta-analysis to investigate the prognostic utility of frailty for the outcome of primary brain tumor surgery. We performed a systematic search of the PubMed, EMBASE, and SCOPUS databases for studies investigating the ability of frailty to predict the outcome of primary brain tumor surgery. RESULTS: Meta-analysis of the information provided in the thirteen studies that made up our sample. Hospital length of stay (effect size 0.94; 95% confidence interval [CI]: 0.37, 1.51; p: 0.00), postoperative complications (effect size 10.31; 95% CI: -5.88, 26.86; p: 0.21), readmission (effect size 0.82; 95% CI: 0.23, 1.41; p: 0.01), nonroutine discharge (effect size 1.07; 95% CI: 0.48, 1.65; 0.00), postoperative mortality (effect size 1.48; 95% CI: 0.81, 2.02; p: 0.00), and overall survival (effect size 1.53; 95% CI: 0.29, 2.76; p: 0.02). CONCLUSIONS: This study showed little correlation with postoperative mortality, readmission, nonroutine discharge, length of hospital stay, or overall survival, and fragility had less significance in these areas but showed no statistical significance in predicting postoperative complications following surgery for primary brain tumors.
引用
- Alare K, Muili A, Afolabi S, et al. The Prognostic Utility of Frailty on the Outcomes of Primary Brain Tumor Surgery Patients: A Meta-Analysis. World Neurosurg. 2024. PMID: 39127383. doi:10.1016/j.wneu.2024.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。